Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.62 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.55 |
| ▸ | POLB | P06746 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.53 |
| ▸ | CTSG | P08311 | 2/20 | 0.53 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.53 |
| ▸ | CMA1 | P23946 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | NPC1 | O15118 | 3/20 | 0.51 |
| ▸ | RAB9A | P51151 | 3/20 | 0.51 |
| ▸ | NAAA | Q02083 | 1/20 | 0.51 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.49 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11350660 | 0.93 | HPGD (0.59) | HPGDGAASMN1; SMN2POLBLMNA | |
| SCHEMBL13383872 | 0.90 | ALDH1A1 (0.62) | HPGDGAAPOLBLMNAALDH1A1 | |
| SCHEMBL4449880 | 0.89 | RAB9A (0.60) | HPGDSMN1; SMN2POLBLMNANPC1 | |
| SCHEMBL30996104 | 0.87 | SMN1; SMN2 (0.64) | HPGDGAASMN1; SMN2POLBLMNA | |
| SCHEMBL8332440 | 0.82 | GFER (0.59) | HPGDGAASMN1; SMN2POLBLMNA | |
| SCHEMBL364448 | 0.82 | HPGD (0.87) | HPGDGAASMN1; SMN2POLBLMNA | |
| SCHEMBL3943418 | 0.81 | GAA (0.57) | HPGDGAASMN1; SMN2POLBLMNA | |
| SCHEMBL7758887 | 0.81 | GAA (0.57) | HPGDGAASMN1; SMN2POLBLMNA | |
| SCHEMBL3184986 | 0.81 | GAA (0.57) | HPGDGAASMN1; SMN2POLBLMNA | |
| SCHEMBL4241470 | 0.81 | CYP1A2 (0.60) | GAASMN1; SMN2LMNATSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-9124569-A | — | — | None | — | — | JP | disclosed |
| CN-118272274-B | Lactic acid bacteria starter and application thereof in preparation of blueberry corn peptide fermentation liquor | 齐齐哈尔大学 | 2024-08-09 | — | — | CN | disclosed |
| CN-118272274-A | Lactic acid bacteria starter and application thereof in preparation of blueberry corn peptide fermentation liquor | 齐齐哈尔大学 | 2024-07-02 | — | — | CN | disclosed |
| US-20210289794-A1 | COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE | FLAGSHIP PIONEERING INNOVATIONS V, INC. | 2021-09-23 | — | — | US | disclosed |
| US-10752640-B2 | Compounds active towards bromodomains | NUEVOLUTION A/S (DK) | 2020-08-25 | — | — | US | disclosed |
| EP-3661941-A1 | THIAZOLOPYRIDINE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS | Merck Patent GmbH (DE) | 2020-06-10 | — | — | EP | disclosed |
| WO-2020011147-A1 | RORγ ANTAGONIST AND APPLICATION THEREOF IN MEDICINE | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2020-01-16 | — | — | WO | disclosed |
| WO-2019025099-A1 | THIAZOLOPYRIDINE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS | MERCK PATENT GMBH (DE) | 2019-02-07 | — | — | WO | disclosed |
| US-20170349607-A1 | COMPOUNDS ACTIVE TOWARDS BROMODOMAINS | NUEVOLUTION A/S (DK) | 2017-12-07 | — | — | US | disclosed |
| US-9409917-B2 | Heterocyclic amide derivatives as P2X7 receptor antagonists | ACTELION PHARMACEUTICALS LTD. (CH) | 2016-08-09 | — | — | US | disclosed |
| US-5723165-A | ARTIFICIAL SWEETENERS | AJINOMOTO CO., INC. (JP) | 1998-03-03 | — | — | US | disclosed |
| EP-0776883-A1 | Adduct salts of substituted benzylamine and a process for optically resolving them | Ajinomoto Co., Inc. (JP) | 1997-06-04 | — | — | EP | disclosed |
| JP-H09124569-A | PRODUCTION OF BENZAMIDE DERIVATIVE | DAINIPPON INK & CHEM INC | 1997-05-13 | — | — | JP | disclosed |
| EP-0719789-A1 | Process of producing alpha-L-aspartyldipeptide amide derivatives | Ajinomoto Co., Ltd. (JP) | 1996-07-03 | — | — | EP | disclosed |
| EP-0691346-A1 | Novel aspartyldipeptide derivatives and sweetener | Ajinomoto Co., Inc. (JP) | 1996-01-10 | — | — | EP | disclosed |
| US-4678611-A | Novel dyestuff intermediates and use thereof for the manufacture of novel azo dyes | CIBA-GEIGY CORPORATION (US) | 1987-07-07 | — | — | US | disclosed |
| US-4360460-A | Novel azo dyes having a 4-sulfo-5-aminomethyl naphthalene coupling moiety | CIBA-GEIGY AG (CH) | 1982-11-23 | — | — | US | disclosed |
| US-4288363-A | Novel azo dyes having 2-amino-5-aminomethyl-7-sulfo naphthalene coupling moiety | CIBA-GEIGY CORPORATION (US) | 1981-09-08 | — | — | US | disclosed |
| US-4126609-A | AZO DYESTUFF WITH A FIBER-REACTIVE GROUP ATTACHED TO A NAPHTHALENE SULPHONIC ACID COMPONENT | BAYER AKTIENGESELLSCHAFT (DE) | 1978-11-21 | — | — | US | disclosed |
| US-4049704-A | AZO REACTIVE DYES | BAYER AKTIENGESELLSCHAFT (DT) | 1977-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170349607-A1 | COMPOUNDS ACTIVE TOWARDS BROMODOMAINS | BRD4, BRD3, BRDT | HPGD 2141/4885GAA 1396/4885SMN1; SMN2 2459/4885 |
| US-10752640-B2 | Compounds active towards bromodomains | BRD4, BRD3, BRDT | HPGD 2141/4885GAA 1396/4885SMN1; SMN2 2459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.